UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
4 hedge funds and large institutions have $603K invested in Proshares UltraPro NASDAQ Biotechnology in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
4
Calls
$784K
Puts
$34K
Net Calls
+$750K
Net Calls Change
-$1.24M
Top Buyers
1 |
CG
Cutler Group
San Francisco,
California
|
+$23K |
2 |
Morgan Stanley
New York
|
+$21.6K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$569K |
2 |
VF
Virtu Financial
New York
|
-$429K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$103K |
4 |
Jane Street
New York
|
-$99.8K |
5 |
UBS Group
Zurich,
Switzerland
|
-$76K |